Skip Navigation LinksHome > September/October 2009 - Volume 16 - Issue 5 > Hormone use and lung cancer incidence: the Rancho Bernardo c...
Menopause:
doi: 10.1097/gme.0b013e3181a1ba04
Articles

Hormone use and lung cancer incidence: the Rancho Bernardo cohort study

Smith, Joshua R. MPH; Barrett-Connor, Elizabeth MD; Kritz-Silverstein, Donna PhD; Wingard, Deborah L. PhD; Al-Delaimy, Wael K. MD, PhD

Collapse Box

Abstract

Objective: This study examines the association of hormone use and lung cancer among women.

Methods: This is a prospective study of 2,861 women aged 31 to 79 years from the Rancho Bernardo cohort. After enrollment in 1972 to 1974, women were followed up for 31 years for morbidity and mortality. Incident lung cancer was based on self-report or death certificates. Diagnosis was validated from the California Cancer Registry for cases that occurred after 1988. Cox proportional hazard models were used to estimate the adjusted association of hormone use and lung cancer.

Results: During the 31-year follow-up, 87 women developed lung cancer. There was no association between hormone use and lung cancer (hazard ratio, 1.13; 95% CI, 0.73-1.73). Stratification by age 55 years (proxy for menopause status) showed divergent results. In women 55 years and older, lung cancer risk was 1.58 (95% CI, 0.95-2.53), whereas in women younger than 55 years, lung cancer risk was 0.44 (95% CI, 0.16-1.23). The confidence intervals for both groups contained the null value.

Conclusions: Although not statistically significant, our results from a long follow-up suggest that postmenopausal women on hormone therapy may have an increased risk of lung cancer, whereas younger women do not.

©2009The North American Menopause Society

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.